Confo Therapeutics
Ghent, Belgium· Est. 2015
Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
Private Company
Total funding raised: $167M
About
Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
AntibodiesBiologics
Funding History
3Total raised:$167M
Series C$75MJan 15, 2023
Series B$52MDec 15, 2020
Series A$40MJun 15, 2018